Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

5-HT antagonists in development at Synthelabo for cardiovascular and other disorders

Nov. 18, 1998

Synthesis and use of novel ET-antagonist series disclosed by Merck KGaA

Nov. 18, 1998

Cytel receives FDA grant to further development of selectin inhibitor

Nov. 18, 1998

Collateral Therapeutics draws nearer to an effective gene therapy for CHF

Nov. 17, 1998

Na+/Ca2+ exchange inhibitors patented by Taisho

Nov. 16, 1998

More news from AHA: azimilide prevents atrial fibrillation

Nov. 16, 1998

New cytokine modulator from Schering-Plough is active in models of endotoxemia

Nov. 13, 1998

Renal protective effect of efonidipine in hypertensive patients

Nov. 13, 1998

Serum complement activation is implicated in the pathogenesis of CHF

Nov. 13, 1998

BG-9719 has potent natriuretic effects in patients with CHF

Nov. 13, 1998

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...